Major Pharma Companies Including Merck Funding the Trial Site during the Study By Michael B. Goodkin MD, FACC | TrialSite News | June 9, 2021 Although a great majority of ivermectin-based studies have indicated real promise, one particular study conducted by a small trial site in Colombia received unprecedented media attention when the study results […]
Source